Classical Hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Classical Hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-07-17Clinical Trial Update: Pembrolizumab Followed by Chemotherapy for the Treatment of Patients With Classical Hodgkin Lymphoma [Phase 2]
A Phase 2 study evaluating pembrolizumab followed by chemotherapy for classical Hodgkin lymphoma is described. The trial is currently active…
-
CLINICAL_TRIALS research · 2025-06-24Clinical Trial Update: Changing Paragidms In The Prognostic Assessment Of Hodgkin Lymphoma
This clinical trial aims to change paradigms in the prognostic assessment of classical Hodgkin lymphoma and is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-06-17Clinical Trial Update: CC-486 and Nivolumab for the Treatment of Hodgkin Lymphoma Refractory to PD-1 Therapy or Relapsed [Phase 1]
Phase 1 trial evaluating CC-486 (oral azacitidine) in combination with nivolumab for patients with recurrent or refractory classical Hodgkin…
-
CLINICAL_TRIALS trial_result · 2025-06-12Clinical Trial Update: Immunotherapy (Nivolumab or Brentuximab Vedotin) Plus Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III-IV Classic Hodgkin Lymphoma [Phase 3]
This Phase 3 trial investigates nivolumab or brentuximab vedotin in combination with chemotherapy for newly diagnosed stage III-IV classical…
-
CLINICAL_TRIALS trial_result · 2025-05-30Clinical Trial Update: Itacitinib + Everolimus in Hodgkin Lymphoma [Phase 1, Phase 2]
Phase 1/2 trial updating the combination of Itacitinib and Everolimus for Classical Hodgkin lymphoma with results posted in 2025.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-05-02Clinical Trial Update: Safety and Preliminary Efficacy Assessment of AZD7789 in Patients With Relapsed or Refractory Classical Hodgkin Lymphoma [Phase 1]
Phase 1 trial update reports safety and preliminary efficacy of AZD7789 in patients with relapsed or refractory classical Hodgkin lymphoma. …
-
CLINICAL_TRIALS research · 2025-04-08Clinical Trial Update: Phase II Trial of Anti-PD-1 Antibody Treatment and Radiotherapy in Early-stage Favorable Classic Hodgkin Lymphoma [Phase 2]
Phase II trial evaluating an anti-PD-1 antibody in combination with radiotherapy for early-stage favorable Classical Hodgkin Lymphoma; the s…
-
CLINICAL_TRIALS trial_result · 2025-04-03Clinical Trial Update: Nivolumab and AVD in Early-stage Unfavorable Classical Hodgkin Lymphoma [Phase 2]
This document reports completion of a Phase 2 trial evaluating nivolumab plus the AVD chemotherapy regimen in patients with early-stage unfa…
-
CLINICAL_TRIALS trial_result · 2025-04-03Clinical Trial Update: Abscopal Effect of Radiotherapy and Nivolumab in Relapsed Hodgkin Lymphoma After Anti-PD1 Therapy [Phase 2]
A Phase 2 trial evaluates whether adding radiotherapy to nivolumab can produce abscopal anti-tumor effects in relapsed classical Hodgkin lym…
-
CLINICAL_TRIALS research · 2025-04-02Clinical Trial Update: Study of Magrolimab and Pembrolizumab in Relapsed or Refractory Classic Hodgkin Lymphoma [Phase 2]
Phase 2 clinical trial evaluating magrolimab in combination with pembrolizumab for relapsed or refractory classical Hodgkin lymphoma. The st…
-
CLINICAL_TRIALS trial_result · 2025-03-26Clinical Trial Update: Safety of Allogeneic Hematopoietic Cell Transplantation (HCT) For Patients With Classical Hodgkin Lymphoma (CHL) Treated With Nivolumab
The update examines safety of allogeneic hematopoietic cell transplantation in patients with classical Hodgkin lymphoma who were treated wit…
-
CLINICAL_TRIALS research · 2025-02-27Clinical Trial Update: Sintilimab Plus AVD in Pediatric Low/Moderate Risk Hodgkin Lymphoma: A Phase II Study [Phase 2]
Phase II clinical trial evaluating the combination of sintilimab with AVD (doxorubicin, vinblastine, and dacarbazine) in pediatric patients …
-
CLINICAL_TRIALS trial_result · 2025-02-17Clinical Trial Update: Ibrutinib in Treating Patients With Relapsed or Refractory Classical Hodgkin Lymphoma [Phase 2]
Results from a Phase 2 trial evaluating ibrutinib in relapsed or refractory classical Hodgkin lymphoma have been completed and posted.
-
CLINICAL_TRIALS trial_result · 2025-02-10Clinical Trial Update: A Safety Study of SEA-TGT (SGN-TGT) in Advanced Cancer [Phase 1]
Seagen's SEA-TGT (SGN-TGT) Phase 1 safety study in advanced cancers has been terminated. The study enrolled patients across multiple cancer …
-
CLINICAL_TRIALS trial_result · 2025-02-07Clinical Trial Update: Microenvironmental Trial of Classical Hodgkin Lymphoma in Adolescents
A clinical trial titled 'Microenvironmental Trial of Classical Hodgkin Lymphoma in Adolescents' (NCT06814860) sponsored by IRCCS Azienda Osp…
-
CLINICAL_TRIALS trial_result · 2024-10-29Clinical Trial Update: Study of Pembrolizumab (MK-3475) in Participants With Relapsed or Refractory Classical Hodgkin Lymphoma (MK-3475-087/KEYNOTE-087) [Phase 2]
Results from the Phase 2 MK-3475-087 (KEYNOTE-087) study of pembrolizumab in relapsed or refractory classical Hodgkin lymphoma have been com…
-
CLINICAL_TRIALS trial_result · 2024-10-16Clinical Trial Update: Study of Safety and Efficacy of Pembrolizumab and Chemotherapy in Participants With Newly Diagnosed Classical Hodgkin Lymphoma (cHL) (MK-3475-C11/KEYNOTE-C11) [Phase 2]
A Phase 2 study evaluating the safety and efficacy of pembrolizumab in combination with chemotherapy for newly diagnosed classical Hodgkin l…
-
CLINICAL_TRIALS trial_result · 2024-08-28Clinical Trial Update: AZD4573 as Monotherapy or in Combinations With Anti-cancer Agents in Patients With r/r PTCL or r/r cHL [Phase 2]
Phase 2 trial evaluating AZD4573 as monotherapy or in combination for relapsed/refractory peripheral T-cell lymphoma and relapsed/refractory…
-
CLINICAL_TRIALS research · 2024-08-23Clinical Trial Update: Pembrolizumab in Combination With Salvage Chemotherapy for First-relapsed or Refractory Classical Hodgkin Lymphoma [Phase 2]
Phase 2 clinical trial evaluating pembrolizumab in combination with salvage chemotherapy for first-relapsed or refractory classical Hodgkin …
-
CLINICAL_TRIALS research · 2024-08-23Clinical Trial Update: Pianzumab Combined With AVD Regimen in the Treatment of Newly-diagnosed Advanced Classic Hodgkin Lymphoma [Phase 2]
A Phase 2 clinical trial is evaluating pianzumab in combination with the AVD chemotherapy regimen for newly diagnosed advanced classical Hod…
-
CLINICAL_TRIALS research · 2024-08-21Clinical Trial Update: Chidamide+Decitabine Plus Anti-PD-1 Antibody for Patients With R/R cHL Who Are Transplant-ineligible or Refused Transplant. [Phase 2]
A Phase 2 clinical trial evaluating chidamide plus decitabine and an anti-PD-1 antibody in patients with relapsed/refractory classical Hodgk…
-
CLINICAL_TRIALS research · 2024-07-26Clinical Trial Update: Phase II Trial of Individualized Immunotherapy in Early-Stage Unfavorable Classical Hodgkin Lymphoma [Phase 2]
Phase II clinical trial investigating individualized immunotherapy for early-stage unfavorable classical Hodgkin lymphoma is currently recru…
-
CLINICAL_TRIALS research · 2024-07-03Clinical Trial Update: Fitness-adapted, Pembrolizumab-based Therapy for Untreated Classical Hodgkin Lymphoma Patients 60 Years of Age and Above [Phase 2]
This clinical trial update describes a Phase 2 study of a fitness-adapted, pembrolizumab-based regimen for untreated classical Hodgkin lymph…
-
CLINICAL_TRIALS research · 2024-06-24Clinical Trial Update: A Study of IMM01 Plus Tiselizumab Versus Physician's Choice Chemotherapy in PD(L)1-refractory Classical Hodgkin Lymphoma [Phase 3]
Phase 3 trial evaluating IMM01 plus Tiselizumab versus physician's choice chemotherapy in PD-L1-refractory classical Hodgkin lymphoma; study…
-
CLINICAL_TRIALS other · 2024-05-13Clinical Trial Update: HD21 for Advanced Stages [Phase 3]
Phase 3 clinical trial update for HD21 in advanced classical Hodgkin lymphoma; the study is currently active but not recruiting.